Psoriasis. Psoriasis
Conditions
Interventions
Intervention 1: Intervention group: Group A of Lactocare bio-fermentable capsule drug (Lactocare), the manufacturer of Danesh Banyan Biofermentation Company, which contains bacteria (Lactobacillus rha
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: All people between 18 and 70 years old Patients with plaque psoriasis who are treated with topical corticosteroids Patients with plaque psoriasis who have not received treatment with systemic drugs or at least three months have passed since the discontinuation of systemic drugs for their treatment and have not received astertine.
Exclusion criteria
Exclusion criteria: pregnancy People undergoing chemotherapy People with a history of any skin disease History of taking antibiotics in the previous 2 weeks or symptoms of bacterial infection Diagnosis of liver disease with Child-Pugh C index Renal failure with serum creatinine >1.5 mg/dl People with a history of receiving acitretin History of any type of surgery in the last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PASI Score. Timepoint: The first visit and 4 weeks later and 12 weeks after the first visit. Method of measurement: PASI score.;Patient satisfaction rate. Timepoint: It will be used after 2-3 weeks from the start of the medication until the end of the treatment process. Method of measurement: Standard questionnaire (treatment satisfaction questionnaire for Medication) TSQM. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArghavan Azizpour
Tehran University of Medical Sciences
Outcome results
None listed